A platform for ultra-sensitive biomarker detection to advance disease research and diagnostics.

Tool: Simoa Technology
Description: A platform for ultra-sensitive biomarker detection to advance disease research and diagnostics.
Summary: Simoa Technology by Quanterix is designed to enable the detection of biomarkers at levels previously undetectable in blood and other sample types. This technology supports a wide range of research and diagnostic applications across various therapeutic areas such as neurology, oncology, cardiology, immunology, and infectious disease. Its high sensitivity and precision make it a valuable tool for early disease detection, prognosis, and monitoring treatment efficacy.
Category: Diagnostics
Tags: Laboratory Diagnostics, Cancer Detection, Screening
Use Cases: Researchers use Simoa to detect early biomarkers for Alzheimer's disease in blood samples.; Clinicians leverage Simoa technology for precise monitoring of cancer biomarker levels during treatment.
Platform: Web
Vendor: Quanterix
Target Users: Researcher
Pricing: unclear
Regulatory: not a medical device
Meta: Simoa Technology by Quanterix enables ultra-sensitive detection of biomarkers for research and diagnostics in neurology, oncology, and more.
Content: [Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum](https://www.quanterix.com/press-releases/quanterix-completes-acquisition-of-akoya-biosciences-creating-the-first-integrated-platform-capable-of-measuring-biomarkers-across-the-blood-and-tissue-continuum/ "") [![](https://www.quanterix.com/wp-content/uploads/2023/03/Quanterix-LogoTag_SLATE-Edited.png)](https://www.quanterix.com/) - [Lucent Diagnostics](https://www.lucentdiagnostics.com/) - [Simoa® Technology](https://www.quanterix.com/simoa-technology/) - [Therapeutic Areas](https://www.quanterix.com/therapeutic-areas/) [Neurology](https://www.quanterix.com/therapeutic-areas/neurology/) [Oncology](https://www.quanterix.com/therapeutic-areas/oncology/) [Immunology/Inflammation](https://www.quanterix.com/therapeutic-areas/immunology/) [Infectious Disease](https://www.quanterix.com/therapeutic-areas/infectious-disease/) [COVID-19](https://www.quanterix.com/covid/) [Cardiology](https://www.quanterix.com/therapeutic-areas/cardiology/) - [Products & Services](https://www.quanterix.com/products-and-services/) [Simoa® Assay Kits](https://www.quanterix.com/simoa-assay-kits/) [Simoa® Dry Blood Extraction Kit](https://www.quanterix.com/simoa-assay-kits/simoa-dry-blood-extraction-kit/) LDTs & Assay Services [Simoa® p-Tau 217](https://www.quanterix.com/products-and-services/simoa-p-tau-217/) [Simoa® NfL LDT](https://www.quanterix.com/products-and-services/simoa-neurofilament-light-nfl-ldt/) [LucentAD® pTau 217](https://www.lucentdiagnostics.com/lucentad-p-tau-217/) Instruments [Simoa HD-X Analyzer® – Automated Immunoassays](https://www.quanterix.com/instruments/simoa-hd-x-analyzer/) [Quanterix SR-X® Biomarker Detection System](https://www.quanterix.com/instruments/quanterix-sr-x/) [SP-X® Imaging and Analysis System](https://www.quanterix.com/instruments/the-sp-x-imaging-and-analysis-system/) [Simoa® Accelerator Laboratory](https://www.quanterix.com/products-and-services/pharma-services/) [Homebrew Custom Assay Development](https://www.quanterix.com/products-and-services/homebrew/) [Nova Beads™](https://www.quanterix.com/nova-beads/) [Uman NF-Light™](https://www.quanterix.com/uman/) - [Support & Resources](https://www.quanterix.com/support-and-resources/) [Customer Care & Technical Support](https://www.quanterix.com/customer-care-and-tech-support/) [Safety Data Sheets & Cert. of Analysis](https://www.quanterix.com/sds-and-coas/) [Product Brochures](https://www.quanterix.com/product-brochures/) [Whitepapers & App Notes](https://www.quanterix.com/whitepapers-appnotes/) [Posters](https://www.quanterix.com/posters/) [Publications](https://www.quanterix.com/publications/) [Conferences](https://www.quanterix.com/conferences/) [Webinars](https://www.quanterix.com/webinars/) - [Media Center](https://www.quanterix.com/media-center/) [Press Releases](https://www.quanterix.com/press-releases/) [Videos & Record

Simoa Technology by Quanterix enables ultra-sensitive detection of biomarkers for research and diagnostics in neurology, oncology, and more.

Simoa Technology

Simoa Technology by Quanterix is designed to enable the detection of biomarkers at levels previously undetectable in blood and other sample types. This technology supports a wide range of research and diagnostic applications across various therapeutic areas such as neurology, oncology, cardiology, immunology, and infectious disease. Its high sensitivity and precision make it a valuable tool for early disease detection, prognosis, and monitoring treatment efficacy.

Simoa Technology

Categories

Description

Summary

Use Cases

Platforms

Regulatory Status

API Available

Added to Directory

Target Customer

Contact